| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9155429 | American Heart Journal | 2005 | 8 Pages |
Abstract
The INSTEAD trial is the first randomized trial investigating the role of endoluminal treatment of uncomplicated type B aortic dissection. By the end of December 2004, 125 patients were randomized, accounting for 92% of the target. Final results of the INSTEAD trial should be available in 2006.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Christoph A. MD, Simona MD, Barbara MD, Stephan MD, Wolfgang MD, Tim C. MD, on behalf of the INSTEAD study collaborators on behalf of the INSTEAD study collaborators,